Breaking News
Translate

COVID-19: We’ve tightened surveillance at entry points over fake Chloroquine, says NAFDAC

Kindly Share This Story:

Warns importers, wholesalers, retailers against patronising drug

By Joseph Erunke

COVID-19: NAFDAC orders manufacturing of Chloroquine for clinical trial
The National Agency for Food and Drug Administration and Control (NAFDAC)

ABUJA-THE National Agency for Food and Drug Administration and Control, NAFDAC, Monday, said it had tightened its surveillance in all ports of entry to avert importation of fake Chloroquine currently in circulation.

The fake chloroquine phosphate 250mg tablets, manufactured by Jiangsu pharmaceutical Inc, Astral pharmaceutical New Bhupalpura, China, according to the agency, was labeled with “NAFDAC No.: 028060.”

READ ALSO;COVID-19: Ganduje extends stay at home for civil servants by two weeks

Director-General of NAFDAC, Prof Mojisola Adeyeye, in a statement warning both importers, wholesalers, and retailers against patronising the drugs said the agency had equally heightened surveillance in the 36 states and the Federal Capital Territory, FCT, to prevent its distribution and sale.

“All importers, wholesalers, and retailers are hereby cautioned to desist from illegal importation, distribution, and sale of falsified chloroquine phosphate 250mg tablets,” she said while adding that, “NAFDAC has strengthened its surveillance in all ports of entry to prevent illegal importation of the falsified chloroquine phosphate 250mg tablets.”

The NAFDAC boss informed that her agency was alerted of the dangerous drug by the World Health Organisation, WHO, which said the tablets were in circulation in Cameroon.

Adeyeye said: “The falsified chloroquine phosphate 250mg tablets were manufactured by Jiangsu pharmaceutical Inc, Astral pharmaceutical New Bhupalpura, China.

“The tablets manufactured by these companies have no Active Pharmaceutical Ingredient (API) and are in packs of 1000 tablets.

“The use of the falsified chloroquine phosphate 250mg tablets may result in treatment failure and could even cause death.”

“The Astral pharmaceuticals, New Bhupalpura, China is labeled with fake NAFDAC registration No. 0587612 and advised the general public to be aware of this drug.

“All importers, wholesalers, and retailers are hereby cautioned to desist from illegal importation, distribution, and sale of falsified chloroquine phosphate 250mg tablets.

“NAFDAC has strengthened its surveillance in all ports of entry to prevent illegal importation of the falsified chloroquine phosphate 250mg tablets.

“The agency has also heightened surveillance in the 36 states and the Federal Capital Territory (FCT) to prevent distribution and sale of this falsified drug.

“Healthcare providers and other members of the public are advised to be vigilant and contact the nearest NAFDAC office with any information on the falsified chloroquine,” she further said.

According to her, anyone in possession of the fake chloroquine should submit it to the nearest NAFDAC office.

Kindly Share This Story:
All rights reserved. This material and any other digital content on this platform may not be reproduced, published, broadcast, written or distributed in full or in part, without written permission from VANGUARD NEWS.

Disclaimer

Comments expressed here do not reflect the opinions of vanguard newspapers or any employee thereof.
Do NOT follow this link or you will be banned from the site!